. Inhibition of miR-133 leads to a myogenic phenotype in early somites, but not in differentiating somites. Embryos were injected with FITC-labelled antagomir-133 (AM133) at HH14/15 or HH20. Whole mount in situ hybridisation was performed for Myf5, MyoD, Mgn or Pax3 as indicated. (A) 9 hour incubation, (B) 24 hour incubation post-injection. (C) AM133-injected into interlimb somites at HH20 and incubated for 24 hours. Antisense probes (purple), FITC-labelled antagomir (red). Number of embryos indicated on each panel. White arrowheads indicating loss of expression on injected side; black arrowheads indicating reduced expression or no change in expression on injected side. (D) Immunostaining for Cas3, an apoptosis marker, in embryos injected with AM133 at HH14/15 and incubated for 9 hours show no difference in AM133 injected side compared to contralateral non-injected side. Scale bar 50 μm. terms of genes expressed at higher levels in AM133 injected somites were associated with angiogenesis and tube morphogenesis. (B) However, the false discovery rates (FDRs) for these were significantly higher compared to GO terms associated with the downregulated DE genes. 145: doi:10.1242/dev.159657: Supplementary information 
